CDSCO Examines Risks of Brand Name Extensions Across Different Drug Formulations
CDSCO has invited stakeholder feedback on drug brand name extensions amid concerns over therapeutic confusion and patient safety, with comments due by 17 July 2026.
DGHS
Use of “Dr.” by Physiotherapists Under Examination: DGHS Directive Withdrawn for Review
DGHS directive restricting physiotherapists from using the prefix “Dr.” has been withdrawn for further review following legal challenges and professional objections.